These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 16025649)

  • 21. Written patient information on prescription drugs. The evolution of government and voluntary programs in the United States.
    Nightingale SL
    Int J Technol Assess Health Care; 1995; 11(3):399-409. PubMed ID: 7591542
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigation of the boxed warnings in package inserts of prescription medicines for medical professionals in Japan.
    Mino Y; Naito T; Ohshiro J; Yamada T; Kawakami J
    Pharm Pract (Granada); 2022; 20(4):2733. PubMed ID: 36793916
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of German package inserts.
    Fuchs J; Hippius M; Schaefer M
    Int J Clin Pharmacol Ther; 2006 Jan; 44(1):8-13. PubMed ID: 16425965
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of pharmacokinetic data provided in Japanese package inserts and interview forms focusing on urinary excretion of pharmacologically active species.
    Ohno Y; Kusama M; Hisaka A; Yanagihara Y; Suzuki H
    Yakugaku Zasshi; 2006 Jul; 126(7):489-94. PubMed ID: 16819270
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical pharmacology information in summaries of product characteristics and package inserts.
    Arguello B; Fernandez-Llimos F
    Clin Pharmacol Ther; 2007 Nov; 82(5):566-71. PubMed ID: 17410119
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Research on Insufficient Information for Pharmaceutical Products].
    Tomita T
    Yakugaku Zasshi; 2017; 137(12):1497-1504. PubMed ID: 29199258
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The way for carrying medicine and its containers (X): "patent medicine and carrying it in the Edo Period"].
    Hattori A
    Yakushigaku Zasshi; 1993; 28(1):28-32. PubMed ID: 11639716
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A 50-year history of new drugs in Japan-the development and trends of hemostatics and antithrombotic drugs].
    Ozawa H; Abiko Y; Akimoto T
    Yakushigaku Zasshi; 2003; 38(1):93-105. PubMed ID: 14570069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Conformity of package inserts information to regulatory requirements among selected branded and generic medicinal products circulating on the East African market.
    Sillo HB; Masota NE; Kisoma S; Rago L; Mgoyela V; Kaale EA
    PLoS One; 2018; 13(5):e0197490. PubMed ID: 29787579
    [TBL] [Abstract][Full Text] [Related]  

  • 30. What has been happening with over-the-counter drug regulation.
    Stringer S
    Food Drug Law J; 1998; 53(4):633-41. PubMed ID: 10557581
    [No Abstract]   [Full Text] [Related]  

  • 31. ["Holtos," a Patented Medicine of the Late Edo Era--Wrapping Style, Statement of Medicine Efficacy, and Tablet Form].
    Nojiri K
    Yakushigaku Zasshi; 2015; 50(2):196-204. PubMed ID: 27149785
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Teratology public affairs committee position paper: Pregnancy labeling for prescription drugs: Ten years later.
    Public Affairs Committee of the Teratology Society
    Birth Defects Res A Clin Mol Teratol; 2007 Sep; 79(9):627-30. PubMed ID: 17663419
    [No Abstract]   [Full Text] [Related]  

  • 33. [The way for carrying medicine and its containers (VIII): "Drug information by packaging in the Edo Period (1600-1867)"].
    Hattori A
    Yakushigaku Zasshi; 1992; 27(2):72-7. PubMed ID: 11639709
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of information on the pharmacokinetic interactions of Ca antagonists in the package inserts from three countries (Japan, USA and UK).
    Saito M; Hirata-Koizumi M; Miyake S; Hasegawa R
    Eur J Clin Pharmacol; 2005 Aug; 61(7):531-6. PubMed ID: 16041596
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Commentary: Patient package inserts. I. Nature, notions, and needs.
    Joubert P; Lasagna L
    Clin Pharmacol Ther; 1975 Nov; 18(5 Pt 1):507-13. PubMed ID: 1183137
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Modern medicine environment and adaptation of Korean trader for medicinal herbs from the late 19th century to the early 20th century].
    Yang J
    Uisahak; 2006 Dec; 15(2):189-209. PubMed ID: 17575704
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Issues on package inserts of percutaneous tracheostomy kits].
    Mori M; Noguchi T
    Masui; 2007 Sep; 56(9):1104-10. PubMed ID: 17877059
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Critical Evaluation of Pharmacogenetic Information in Package Inserts for Selected Drugs Marketed in India and Its Comparison With US FDA-Approved Package Inserts.
    Pai SA; Kshirsagar N
    J Clin Pharmacol; 2016 Oct; 56(10):1232-42. PubMed ID: 26873003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of prescribing information for generic drugs manufactured in the Middle East and marketed in Saudi Arabia.
    Gebran N; Al Haidari K
    Ann Saudi Med; 2006; 26(3):192-9. PubMed ID: 16861873
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prescription drug products that require patient package inserts; ampicillin and phenytoin--Food and Drug Administration. Final rule.
    Fed Regist; 1981 Jan; 46(1):28. PubMed ID: 10249520
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.